LENZ

NASDAQ · Pharmaceuticals

Lenz Therapeutics Inc

Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$5.36

+0.14 (+2.68%)

As of Aug 8, 10:22 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 85%

Hold 2 15%

Sell 0 0%

Price Target

Analyst Price Target +160.8% upside

Low Target $9.74

Average Target $13.98

High Target $16.17

Current Price $5.36

Current
$5.36

Target
$13.98

$9.74 $13.98 avg $16.17

Scenario Analysis

Bear Case

$9.74

81.7%

Low target

Base Case

$13.98

+160.8%

Avg target

Bull Case

$16.17

+201.7%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$50.40

-89.4% from high

52-Week Low

$4.68

+14.5% from low

Target vs 52W High

$13.98

-72.3% vs high

Next Earnings Report

Aug 11, 2026 · After Market Close

tomorrow

EPS Est: $-1.10

Earnings in 1 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%